AtaiBeckley Inc.
IPOPublic · United States · Founded 2025 · $285.0M raised
- Employees
- 51–200
- Founded
- 2025
- Business Model
- B2B
- Total Funding
- $285.0M
- Last Round
- $160.0M Series DMar 2021
- Rounds
- 2
- Type
- Public
About
Clinical-stage biopharmaceutical company developing effective, rapid-acting mental health treatments formed from merger of atai Life Sciences and Beckley Psytech.
Summary
AtaiBeckley Inc. is a Biotech company based in United States, founded in 2025. It has raised $285.0M in total across 2 rounds, most recently a $160.0M Series D round in Mar 2021. Investors include Multiple investors.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Funding History
Jun 2021
Sign up to see all 3 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...

Global fertility clinics platform
Biopharmaceutical services company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.

Specialty pharmaceutical company
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...